News & Events
Varana Capital Leads Arcuro Medical’s Series A Financing, Driving Strategic Growth in 2025
Varana Capital is pleased to announce their role as lead investor in the initial closing of Arcuro Medical’s Series A financing round.
6 January 2025
Varana Capital is pleased to announce their role as lead investor in the initial closing of Arcuro Medical’s Series A financing round. This funding round, which includes participation from other notable investors, including Trendlines and Consensus Business Group, will support Arcuro’s next phase of growth and innovation. The Series A remains open for additional investment, offering further opportunities for stakeholders to join in advancing Arcuro Medical’s impactful work in the medical device industry.
Arcuro Medical concluded a pivotal 2024 with several key achievements, including:
- Establishing a new U.S. organization and hiring key sales leadership
- Adding new U.S. and international distribution partners
- Achieving a significant product development milestone with the 510(k) submission of a new product line
- Surpassing 5,000 global SuperBall cases
These accomplishments position Arcuro Medical for significant growth as it enters 2025 with an enhanced product portfolio and expanded market reach.
This news was published on PRNewswire.
Our investment in Arcuro Medical is a testament to the Varana Capital Chai Fund’s mission to support Israeli companies making a global impact. As the largest Israeli opportunity fund, the Chai Fund was created to invest in transformative innovations, and Arcuro’s revolutionary medical technology exemplifies this by providing better outcomes for orthopedic injuries. If you know any surgeons specializing in knees, please refer them to us: We are confident we can make a meaningful impact on their practice and, most importantly, their patients’ lives.
Ezra Gardner, Varana Capital Co-Founder and CIO
We are excited and grateful to welcome Varana Capital as the lead investor in our Series A, alongside our valued existing investors. Supported by this funding, our team is enthusiastic to kick off a strong 2025, delivering on our mission to assist surgeons in improving their patient’s quality of life.
Jamal Rushdy, Arcuro Medical CEO
See More News
FruitSpec raises $5 million
FruitSpec’s Yield Management Platform provides digital visibility of fruit yield data to entire supply-chain production units
Phytolon secures $4.1 million in funding
Funding for fermentation-based technology for the production of food colors
